Introduction
-
CAS 176699-34-6 | CEFMA-002 : Cefmatilen hydrochloride hydrate
(World's Largest Pharmaceutical Supplier)
CAS Number: 176699-34-6
Stock: 999g
Assay: 0.00%

Details
CAS Number:176699-34-6
Catalog Number:
Chemcial Name:
MW(Molecular Weight):
MF(Molecular Formula):
SMILES:CAS 176699-34-6 is a chemical compound known as rivaroxaban. It is a medication that belongs to the class of direct oral anticoagulants (DOACs) and is used for the prevention and treatment of blood clots.Rivaroxaban is an oral, selective inhibitor of factor Xa, a key enzyme involved in the blood clotting process. Its chemical formula is C19H18ClN3O5S, and it is available in tablet form for oral administration.One of the primary uses of CAS 176699-34-6 is in the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) following orthopedic surgeries such as knee or hip replacement. It offers an alternative to traditional anticoagulant therapy with heparin or warfarin, as it can be taken orally and does not require regular monitoring of blood clotting levels.Additionally, rivaroxaban is prescribed for the treatment of DVT and PE, as well as for the prevention of recurrent DVT and PE in patients who have completed initial anticoagulation therapy. It helps to reduce the risk of blood clots from forming or growing, thereby preventing potentially life-threatening complications.Furthermore, rivaroxaban has been approved for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (irregular heart rhythm). It is used as an alternative to warfarin, offering a more convenient treatment option without the need for frequent blood tests and dietary restrictions associated with warfarin therapy.It is important to note that rivaroxaban, like other anticoagulant medications, carries a risk of bleeding. Patients taking CAS 176699-34-6 should follow their healthcare provider's instructions carefully and report any signs of unusual bleeding or bruising. Dosage adjustments may be necessary for individuals with certain medical conditions or those taking other medications that can interact with rivaroxaban.In conclusion, CAS 176699-34-6, or rivaroxaban, is a direct oral anticoagulant used for the prevention and treatment of blood clots. It offers a convenient and effective alternative to traditional anticoagulation therapy, particularly in orthopedic surgeries, venous thromboembolism management, and non-valvular atrial fibrillation. However, it should be used under medical supervision due to the risk of bleeding.